Blood Screening Market Segment by Regions & Industry Analysis by Players till 2031

The Blood Screening Market, estimated at USD 3.02 billion in 2023, is on track for substantial growth in the years ahead. Forecasts suggest a robust upward trajectory, with projections indicating a rise to USD 7.37 billion by 2031. This anticipated expansion is underpinned by a strong compound annual growth rate (CAGR) of 11.8% throughout the forecast period from 2024 to 2031. As the importance of blood screening in healthcare systems worldwide continues to grow, driven by factors such as the increasing prevalence of infectious diseases and the rising demand for blood transfusions, the market for blood screening technologies and services is poised for significant development. Advances in screening methodologies and technologies are expected to play a crucial role in meeting the evolving needs of healthcare providers and ensuring the safety and efficacy of blood products, thereby driving further growth in this dynamic market.